{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:41:11Z","timestamp":1778262071143,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":363,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.14338\/ijpt-22-00021.1","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T10:28:30Z","timestamp":1671445710000},"page":"18-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes"],"prefix":"10.1016","volume":"9","author":[{"given":"Michael S.","family":"Rutenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford S.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason S.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Awad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randal H.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy C.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharatsinh Gharia","family":"MBBS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert C.","family":"Wolfsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani M.","family":"Babiker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Romaine C.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.14338\/IJPT-22-00021.1_bib1","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2008.20.5864","article-title":"Predictors of postoperative quality of life after esophagectomy for cancer","volume":"27","author":"Djarv","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0959-8049(03)00270-3","article-title":"European Organisation for R, Treatement of Cancer G, Quality of Life G. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer","volume":"39","author":"Blazeby","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.14338\/IJPT-22-00021.1_bib3","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1200\/JCO.2011.40.3568","article-title":"Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery","volume":"30","author":"Derogar","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ijrobp.2005.08.002","article-title":"Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery","volume":"64","author":"Wang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-22-00021.1_bib5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijrobp.2013.04.006","article-title":"Predictors of postoperative complications after trimodality therapy for esophageal cancer","volume":"86","author":"Wang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-22-00021.1_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejca.2018.02.025","article-title":"Long-term survival improvement in oesophageal cancer in the Netherlands","volume":"94","author":"van Putten","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.14338\/IJPT-22-00021.1_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.canep.2012.07.009","article-title":"Oesophageal cancer survival in Europe: a EUROCARE-4 study","volume":"36","author":"Gavin","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.14338\/IJPT-22-00021.1_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/jgh.13289","article-title":"Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis","volume":"31","author":"Njei","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.14338\/IJPT-22-00021.1_bib9","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.14338\/IJPT-22-00021.1_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijrobp.2008.05.014","article-title":"Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer","volume":"72","author":"Zhang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-22-00021.1_bib11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1118\/1.4940789","article-title":"Motion-robust intensity-modulated proton therapy for distal esophageal cancer","volume":"43","author":"Yu","year":"2016","journal-title":"Med Phys"},{"key":"10.14338\/IJPT-22-00021.1_bib12","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.ijrobp.2010.07.2001","article-title":"Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study","volume":"81","author":"Welsh","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-22-00021.1_bib13","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3390\/cancers6042356","article-title":"Analysis of intensity-modulated radiation therapy (IMRT), pProton and 3D conformal radiotherapy (3D-CRT) for reducing perioperative cardiopulmonary complications in esophageal cancer patients","volume":"6","author":"Ling","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.14338\/IJPT-22-00021.1_bib14","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.19.02503","article-title":"Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2017.07.034","article-title":"Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or intensity-modulated radiation therapy","volume":"125","author":"Shiraishi","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib16","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/j.ijrobp.2012.01.003","article-title":"Proton beam therapy and concurrent chemotherapy for esophageal cancer","volume":"83","author":"Lin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-22-00021.1_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2017.11.028","article-title":"Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: a propensity matched analysis of the relative risk of proton versus photon-based radiation therapy","volume":"128","author":"Shiraishi","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib18","series-title":"American Joint Committee on Cancer. AJCC Cancer Staging Manual. 8th ed","author":"Amin","year":"2017"},{"key":"10.14338\/IJPT-22-00021.1_bib19","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.21037\/jtd.2019.08.15","article-title":"Role of precision imaging in esophageal cancer","volume":"12","author":"Elsherif","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.14338\/IJPT-22-00021.1_bib20","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib21","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","article-title":"Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial","volume":"36","author":"Yang","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib22","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.20.03697","article-title":"Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO Study)","volume":"39","author":"Hulshof","year":"2021","journal-title":"J Clin Oncol"},{"issue":"Supplement","key":"10.14338\/IJPT-22-00021.1_bib23","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ijrobp.2021.07.045","article-title":"Exclusive chemoradiotherapy with or without radiation dose escalation in esophageal cancer: multicenter phase 2\/3 randomized trial CONCORDE (PRODIGE-26)","volume":"111","author":"Crehange","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-22-00021.1_bib24","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"},{"key":"10.14338\/IJPT-22-00021.1_bib25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fonc.2019.00548","article-title":"Survival of esophageal cancer in China: a pooled analysis on hospital-based studies from 2000 to 2018","volume":"9","author":"Hou","year":"2019","journal-title":"Front Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib26","doi-asserted-by":"crossref","first-page":"866","DOI":"10.14338\/IJPT-14-00018.1","article-title":"Comparing proton beam to intensity modulated radiation therapy planning in esophageal cancer","volume":"1","author":"Wang","year":"2015","journal-title":"Int J Part Ther"},{"key":"10.14338\/IJPT-22-00021.1_bib27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2017.06.2450","article-title":"Comparative outcomes after definitive chemoradiotherapy using proton beam therapy versus intensity modulated radiation therapy for esophageal cancer: a retrospective, single-institutional analysis","volume":"99","author":"Xi","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-22-00021.1_bib28","first-page":"1757","article-title":"Proton beam therapy combined with concurrent chemotherapy for esophageal cancer","volume":"35","author":"Ishikawa","year":"2015","journal-title":"Anticancer Res"},{"key":"10.14338\/IJPT-22-00021.1_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.adro.2017.06.002","article-title":"Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience","volume":"2","author":"Prayongrat","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib30","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00066-016-1034-4","article-title":"Proton therapy posterior beam approach with pencil beam scanning for esophageal cancer: clinical outcome, dosimetry, and feasibility","volume":"192","author":"Zeng","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.14338\/IJPT-22-00021.1_bib31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.21037\/jgo.2016.05.06","article-title":"Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review","volume":"7","author":"Verma","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib32","doi-asserted-by":"crossref","first-page":"748331","DOI":"10.3389\/fonc.2021.748331","article-title":"Executive summary of clinical and technical guidelines for esophageal cancer proton beam therapy from the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees","volume":"11","author":"Chuong","year":"2021","journal-title":"Front Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ijrobp.2021.04.040","article-title":"Strategies for motion robust proton therapy with pencil beam scanning for esophageal cancer","volume":"111","author":"Moller","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-22-00021.1_bib34","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1038\/s41598-021-81058-1","article-title":"Comparison of DNA repair and radiosensitivity of different blood cell populations","volume":"11","author":"Heylmann","year":"2021","journal-title":"Sci Rep"},{"key":"10.14338\/IJPT-22-00021.1_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14338\/IJPT-20-00086","article-title":"Radiation-induced lymphopenia risks of photon versus proton therapy for esophageal cancer patients","volume":"8","author":"Ebrahimi","year":"2021","journal-title":"Int J Part Ther"},{"key":"10.14338\/IJPT-22-00021.1_bib36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.radonc.2019.12.008","article-title":"Mean cardiopulmonary dose and vertebral marrow dose differentially predict lineage-specific leukopenia kinetics during radiotherapy for esophageal cancer","volume":"152","author":"Anderson","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib37","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.21037\/jtd.2020.03.93","article-title":"Dosimetric analysis of lymphopenia during chemoradiotherapy for esophageal cancer","volume":"12","author":"Newman","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.14338\/IJPT-22-00021.1_bib38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.21037\/jgo.2019.01.20","article-title":"Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicity","volume":"10","author":"Zhang","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"10.14338\/IJPT-22-00021.1_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2017.05.037","article-title":"Lymphocyte nadir and esophageal cancer survival outcomes after chemoradiation therapy","volume":"99","author":"Davuluri","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-22-00021.1_bib40","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ijrobp.2021.01.035","article-title":"Circulating lymphocyte counts early during radiation therapy are associated with recurrence in pediatric medulloblastoma","volume":"110","author":"Grassberger","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-22-00021.1_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2016.10.046","article-title":"Does unintentional splenic radiation predict outcomes after pancreatic cancer radiation therapy?","volume":"97","author":"Chadha","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518023002366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518023002366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/theijpt\/article-pdf\/9\/3\/18\/3181554\/i2331-5180-9-3-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/theijpt\/article-pdf\/9\/3\/18\/3181554\/i2331-5180-9-3-18.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:33:09Z","timestamp":1762421589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518023002366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2331518023002366"],"URL":"https:\/\/doi.org\/10.14338\/ijpt-22-00021.1","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14338\/IJPT-22-00021.1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 \u00a9 2022 THE AUTHORS. Published by Elsevier BV on behalf of the Particle Therapy Co-operative Group. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}